Biotechnology in medicine.
作者信息
Green A M
出版信息
Can Med Assoc J. 1984 Mar 1;130(5):558-9.
Abstract
摘要
相似文献
1
Biotechnology in medicine.医学中的生物技术。
Can Med Assoc J. 1984 Mar 1;130(5):558-9.
2
[The X chromosome, fetal hemoglobin and sickle cell anemia].
Nouv Rev Fr Hematol (1978). 1991;33(2):139-41.
3
High Foetal Haemoglobin in Sickle Cell Disease: Not so Protective?镰状细胞病中的高胎儿血红蛋白：并非那么具有保护作用？
EBioMedicine. 2015 Jan 14;2(2):102-3. doi: 10.1016/j.ebiom.2015.01.005. eCollection 2015.
4
Defining stroke risks in sickle cell anemia.镰状细胞贫血中风风险的界定
Nat Genet. 2005 Apr;37(4):340-1. doi: 10.1038/ng0405-340.
5
6
Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia.上位（修饰）基因在调节镰状细胞贫血表型多样性中的作用。
Pediatr Pathol Mol Med. 2001 Mar-Apr;20(2):123-36.
7
Overview of pathophysiology and rationale for treatment of sickle cell anemia.镰状细胞贫血的病理生理学概述及治疗原理
Semin Hematol. 1997 Jul;34(3 Suppl 3):2-7.
8
Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.镰状细胞贫血：靶向胎儿血红蛋白在治疗中的作用。
Clin Pediatr (Phila). 2007 Jun;46(5):386-91. doi: 10.1177/0009922806297751.
9
Molecular crowding limits the role of fetal hemoglobin in therapy for sickle cell disease.分子拥挤限制了胎儿血红蛋白在镰状细胞病治疗中的作用。
J Mol Biol. 2005 Apr 15;347(5):1015-23. doi: 10.1016/j.jmb.2005.02.006.
10
Pulsed-dosing with oral sodium phenylbutyrate increases hemoglobin F in a patient with sickle cell anemia.
Pediatr Blood Cancer. 2008 Feb;50(2):357-9. doi: 10.1002/pbc.21104.
本文引用的文献
1
Monoclonal antibody-defined human lung cell surface protein antigens.单克隆抗体界定的人肺细胞表面蛋白抗原
Cancer Res. 1982 Jan;42(1):150-4.
2
Reactivity of a monoclonal antibody with human ovarian carcinoma.一种单克隆抗体与人卵巢癌的反应性。
J Clin Invest. 1981 Nov;68(5):1331-7. doi: 10.1172/jci110380.
3
Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.通过静脉注射含胞壁酰二肽的脂质体消除自发性转移并激活肺泡巨噬细胞。
Proc Natl Acad Sci U S A. 1981 Mar;78(3):1680-4. doi: 10.1073/pnas.78.3.1680.
4
A unique cell-surface protein phenotype distinguishes human small-cell from non-small-cell lung cancer.
Proc Natl Acad Sci U S A. 1982 Aug;79(15):4650-4. doi: 10.1073/pnas.79.15.4650.
5
A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations.一种单克隆抗体（B72.3）确定了一种新型肿瘤相关抗原在人乳腺癌细胞群体中的分布模式。
Int J Cancer. 1982 May 15;29(5):539-45. doi: 10.1002/ijc.2910290509.
6
Oncogenes.
Lancet. 1983 Aug 6;2(8345):326-30. doi: 10.1016/s0140-6736(83)90300-8.
7
Clinical management of gene expression.基因表达的临床管理。
N Engl J Med. 1982 Dec 9;307(24):1515-6. doi: 10.1056/NEJM198212093072409.
Zotero 插件